Browse diseases

…ebrospinal fluid (CSF) of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Alzheimer’s disease (A…

…d Environmental exposures have been linked to increased risk of amyotrophic lateral sclerosis (ALS); however, their impact on disease progression remains unc…

…allelic intermediate ATXN2 repeat expansions in a pedigree with amyotrophic lateral sclerosis (ALS) through clinical testing prompted us to investigate its r…

…stic paraplegia type 10, Charcot-Marie-Tooth disease type 2 and amyotrophic lateral sclerosis. We discuss the clinical, genetic and prognostic implications o…

…Background Management of amyotrophic lateral sclerosis (ALS) is complicated by heterogeneous presentation and unpredic…

…epeat expansion in C9orf72 are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, family histor…

…ction Robotic rehabilitation on locomotion is a new approach in amyotrophic lateral sclerosis (ALS) and previous studies showed its feasibility. In this stud…

…Delays are described in the diagnosis of Amyotrophic Lateral Sclerosis (ALS) even in studies based in tertiary hospitals, with median …

…MAP2 as a new candidate cerebrospinal fluid (CSF) biomarker for amyotrophic lateral sclerosis (ALS).Methods We measured CSF levels of MAP2 and neurofilament …

…t two decades, a multistep process has been proposed to explain amyotrophic lateral sclerosis (ALS) pathogenesis, implicating genetic factors, environmental …

…ice was analysed with Cox-regression and Log-rank tests.Results Amyotrophic Lateral Sclerosis (ALS) was the most common MND (n=63). Patients with ALS tended …

…, a process that is critically linked to disease progression in amyotrophic lateral sclerosis (ALS). Clinical assessment of progression typically relies on t…